UPMC Enterprises, the commercialization arm of University of Pittsburgh Medical Center has acquired all of Millennium Health’s interest in predictive analytics startup RxAnte. Financial terms of the deal were not disclosed. As part of the deal, RxAnte will continue to operate as an independent company led by its existing management team.
“RxAnte’s technology and services have been a key driver of our stellar performance in ensuring that our members receive the appropriate medications for their conditions, leading to better patient outcomes and effective cost management,” said William H. Shrank, M.D., chief medical officer for the UPMC Insurance Services Division in a statement. “With UPMC’s clinical expertise and the Health Plan’s strength in analytics, we look forward to supporting RxAnte’s product development and advancing our joint goal of providing the highest value from prescription medications.”
